This page is not the official website. Generated by AI, does not constitute any advice. If needed, please click here to visit the corresponding official website.
A trusted partner in pharmaceutical intermediates and custom synthesis, delivering innovation from lab to market for global drug development.
Shanghai Lizhuo Pharmaceutical Technology Co., Ltd. is a subsidiary of Shenzhen Rich Chemical Technology Co., Ltd. Since its establishment, Lizhuo Pharmaceutical has been committed to providing global pharmaceutical companies and new drug research and development institutions with comprehensive R&D and customized production services of pharmaceutical intermediates throughout the entire life cycle—from early clinical research to drug listing.
With a strong foundation in organic chemical synthesis and a dedicated R&D team, we ensure high-quality, reliable, and scalable solutions tailored to the evolving needs of the pharmaceutical industry.
High-purity pharmaceutical intermediates and catalysts for antitumor, antiviral, hypoglycemic, and CNS drug development.
CAS NO.: 81058-27-7
Canagliflozin Intermediate 3; Used in SGLT2 inhibitor synthesis.
CAS NO.: 2169906-55-0
Key intermediate in kinase inhibitor development.
CAS NO.: 61717-82-6
Oxidizing agent used in organic synthesis.
CAS NO.: 2490501-34-1
Intermediate for kinase and antitumor agents.
CAS NO.: 1276666-14-8
Used in orexin receptor antagonist synthesis.
CAS NO.: 187344-92-9
Ligand precursor in transition metal catalysis.
CAS NO.: 6262-51-7
Highly reactive intermediate for specialty synthesis.
CAS NO.: 6262-42-6
Building block for strained ring systems.
From mg to multi-ton scale, we offer end-to-end custom synthesis with strict quality control and IP protection.
Tailored route design, process optimization, and scalable production for novel intermediates and APIs.
Advanced organic chemistry lab with expertise in catalysis, heterocycles, and chiral synthesis.
Strict protocols, full documentation, and analytical validation (HPLC, NMR, MS) for every batch.
Insights and updates from the world of pharmaceutical chemistry.
A black solid is reshaping the competitive landscape of China's precious metal catalyst market. Discover how Lizhuo is advancing sustainable catalytic processes.
The proteomics market will reach USD 41.65 billion in 2025. Researchers demand high-purity intermediates—Lizhuo delivers.
Ready to start a project or need technical support? Reach out to our team today.
Phone: +86 13962513054
Email:
[email protected],
[email protected]
Skype: charleen.chang31
Visit Official WebsiteNotice for Buyers: If you are a buyer, the above information is generated by AI collection and does not constitute any advice. If necessary, please visit the corresponding official website.
For Domain Owners: If you are the domain owner and do not want to be included by fobcompany.info, please contact [email protected] via your corporate email to cancel. We will cancel your inclusion within 3 business days.
如果您是域名所有者 不想被fobcompany.info收录 请用企业邮箱联系[email protected] 取消收录 我们将在3个工作日取消您的收录
Service Request: If you are other domain and want to be included, please contact [email protected]
如果您是其他域名合作 也请联系[email protected]